CoChat

Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants

Open access
Saville, James W., Mannar, Dhiraj, Zhu, Xing, Srivastava, Shanti S., Berezuk, Alison M., Demers, Jean-Philippe, Zhou, Steven, Tuttle, Katharine S., Sekirov, Inna, Kim, Andrew, Li, Wei, Dimitrov, Dimiter S., Subramaniam, Sriram · 2022 · Nature Communications

Published version of a preprint

Cited by 93

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

The Delta and Kappa variants of SARS-CoV-2 co-emerged in India in late 2020, with the Delta variant underlying the resurgence of COVID-19, even in countries with high vaccination rates. In this study, we assess structural and biochemical aspects of viral fitness for these two variants using cryo-electron microscopy (cryo-EM), ACE2-binding and antibody neutralization analyses. Both variants demonstrate escape of antibodies targeting the N-terminal domain, an important immune hotspot for neutralizing epitopes. Compared to wild-type and Kappa lineages, Delta variant spike proteins show modest increase in ACE2 affinity, likely due to enhanced electrostatic complementarity at the RBD-ACE2 interface, which we characterize by cryo-EM. Unexpectedly, Kappa variant spike trimers form a structural head-to-head dimer-of-trimers assembly, which we demonstrate is a result of the E484Q mutation and with unknown biological implications. The combination of increased antibody escape and enhanced ACE2 binding provides an explanation, in part, for the rapid global dominance of the Delta variant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-28324-6

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 35

  1. Dhanasekaran, V. et al. Air travel-related outbreak of multiple SARS-CoV-2 variants. medRxiv https://doi.org/10.1101/2021.07.22.21260854 (2021). · doi:10.1101/2021.07.22.21260854
  2. Farinholt T. et al. Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections. medRxiv https://doi.org/10.1101/2021.06.28.21258780 (2021). · doi:10.1101/2021.06.28.21258780
  3. Campbell, F. et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Eurosurveillance 26, 2100509 (2021). · DOI · Paper page
  4. Tzou, P. et al. Coronavirus Antiviral Research Database (CoV-RDB): an online database designed to facilitate comparisons between candidate anti-coronavirus compounds. Viruses 12, 1006 (2020). · DOI · Paper page
  5. McCallum, M. et al. Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants. bioRxiv https://doi.org/10.1101/2021.08.11.455956 (2021). · DOI
  6. Saito, A. et al. SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity. bioRxiv https://doi.org/10.1101/2021.06.17.448820 (2021). · DOI · Paper page
  7. Lok, S.-M. An NTD supersite of attack. Cell Host Microbe 29, 744–746 (2021). · DOI · Paper page
  8. Liu Y. et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv https://doi.org/10.1101/2021.08.12.456173 (2021). · doi:10.1101/2021.08.12.456173
  9. Li, W. et al. Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA 117, 29832–29838 (2020). · DOI · Paper page
  10. Li, W. et al. High potency of a bivalent human VH domain in SARS-CoV-2 animal models. Cell 183, 429–441.e416 (2020). · DOI · Paper page
  11. Mannar, D. et al. Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding. Cell Rep. 37, 110156 (2021). · DOI · Paper page
  12. Cai, Y. et al. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science 373, 642–648 (2021). · DOI · Paper page
  13. Gobeil, S. M. C. et al. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science 373, eabi6226 (2021). · DOI · Paper page
  14. Salleh, M. Z., Derrick, J. P. & Deris, Z. Z. Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion. Int. J. Mol. Sci. 22, 7425 (2021). · DOI
  15. Zhu, X. et al. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. PLoS Biol. 19, e3001237 (2021). · DOI · Paper page
  16. Ramanathan, M., Ferguson, I. D., Miao, W. & Khavari, P. A. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect. Dis. 21, 1070 (2021). · DOI · Paper page
  17. Zhou, D. et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell 184, 2348–2361.e2346 (2021). · DOI · Paper page
  18. Li, Q. et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell 184, 2362–2371.e2369 (2021). · DOI · Paper page
  19. Wilhelm, A. et al. Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q. medRxiv, https://doi.org/10.1101/2021.08.09.21261704 (2021). · DOI
  20. Zhang, J. et al. Membrane Fusion And Immune Evasion By The Spike Protein of SARS-CoV-2 Delta Variant (Cold Spring Harbor Laboratory, 2021). · doi:10.1101/2021.08.17.456689
  21. Yang, T.-J. et al. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nat. Struct. Mol. Biol. 28, 731–739 (2021). · DOI
  22. Kannan, S. R. et al. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses. J. Autoimmun. 124, 102715 (2021). · DOI · Paper page
  23. Tada, T. et al. Comparison Of Neutralizing Antibody Titers Elicited by mRNA And Adenoviral Vector Vaccine Against SARS-CoV-2 Variants (Cold Spring Harbor Laboratory, 2021). · DOI
  24. Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498–502 (2020). · DOI · Paper page
  25. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e278 (2020). · DOI · Paper page
  26. Hanke, L. et al. A Bispecific Monomeric Nanobody Induces Spike Trimer Dimers And Neutralizes SARS-CoV-2 In Vivo (Cold Spring Harbor Laboratory, 2021). · DOI
  27. Sun, D. et al. Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes. Nat. Commun. 12, 4676 (2021). · DOI
  28. Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020). · DOI · Paper page
  29. Neerukonda, S. N. et al. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. PLoS ONE 16, e0248348 (2021). · DOI
  30. Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017). · DOI · Paper page
  31. Bell, J. M., Chen, M., Baldwin, P. R. & Ludtke, S. J. High resolution single particle refinement in EMAN2.1. Methods 100, 25–34 (2016). · DOI · Paper page
  32. Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004). · DOI · Paper page
  33. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486–501 (2010). · DOI · Paper page
  34. Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. Sect. D Struct. Biol. 74, 814–840 (2018). · DOI · Paper page
  35. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 12–21 (2010). · DOI · Paper page

Cited by

See all 93

Metadata

Authors
Saville, J. W., Mannar, D., Zhu, X., Srivastava, S. S., Berezuk, A. M., Demers, J.-P., Zhou, S., Tuttle, K. S., Sekirov, I., Kim, A., Li, W., Dimitrov, D. S., & Subramaniam, S.
Venue
Nature Communications
Published
2022-02-08
Volume
13
Issue
1
Pages
742-742
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4225501232
Cited by
93
References
18
FWCI
10.21
Type
journal article
Language
en
Open access
gold
Licence
Funders
Canada Excellence Research Chairs, Government of Canada

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. https://app.cochat.ai/papers/10.1038/s41467-022-28324-6
The paper
Saville, J. W., Mannar, D., Zhu, X., Srivastava, S. S., Berezuk, A. M., Demers, J.-P., Zhou, S., Tuttle, K. S., Sekirov, I., Kim, A., Li, W., Dimitrov, D. S., & Subramaniam, S. (2022). Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nature Communications. https://doi.org/10.1038/s41467-022-28324-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.